Raisio and McNeil Amend Benecol Agreement
Cilag will retain exclusive rights to the Benecol brand in Great Britain, Ireland, Belgium, and Luxembourg. McNeil and Cilag will also retain rights in the categories in which they currently hold strong positions in both France and the United States.
25/10/07 Raisio and its United States’ partner, McNeil Nutritionals, LLC, and its European partner, Cilag GmbH International, have signed an amendment to their agreement that will return the rights to the stanol ester compound to Raisio in the United States, Great Britain, France, Ireland, and Benelux countries. In addition, Raisio will gain rights to the Benecol brand in France and the United States in categories in which McNeil and Cilag are not currently active. In return Raisio will make royalty payments and provide marketing support to McNeil and Cilag.
Cilag will retain exclusive rights to the Benecol brand in Great Britain, Ireland, Belgium, and Luxembourg. McNeil and Cilag will also retain rights in the categories in which they currently hold strong positions in both France and the United States.
Raisio aims to be an active player in the growing European, Asian and United States markets for cholesterol-lowering functional foods by introducing innovative product applications. Raisio’s strength in different market areas is its adaptability. This means that Benecol brand products are launched in the market with local partners in applications matching the local consumption habits.
